All and drugs of ingredients of vancomycin (a real world drug study)

---

---

Number of reports submitted per year:

Time on drugs with ingredients of vancomycin when people have All *:

• < 1 month: 100 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 0.0 %
• 2 - 5 years: 0.0 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

Gender of people who have All when taking drugs with ingredients of vancomycin *:

• female: 100 %
• male: 0.0 %

Age of people who have All when taking drugs with ingredients of vancomycin *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 33.33 %
• 30-39: 33.33 %
• 40-49: 0.0 %
• 50-59: 0.0 %
• 60+: 33.33 %

Conditions people have *:

You may use this to check any potential undetected conditions.

1. Fungal Infection: 1 person, 33.33%
2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 33.33%

Other drugs people take *:

You may use this to check any potential interacting drugs.

1. Meropenem: 2 people, 66.67%
2. Voriconazole: 1 person, 33.33%
3. Lorazepam: 1 person, 33.33%
4. Acyclovir: 1 person, 33.33%
5. Ambisome: 1 person, 33.33%
6. Amlodipine: 1 person, 33.33%
7. Calcium Carbonate: 1 person, 33.33%
8. Entecavir: 1 person, 33.33%
9. Furosemide: 1 person, 33.33%
10. Haloperidol: 1 person, 33.33%

Other side effects people have besides All *:

You may use this to check any potential undetected side effects.

1. Weakness: 1 person, 33.33%
2. Swallowing Difficulty: 1 person, 33.33%
3. Rashes (redness): 1 person, 33.33%
4. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 1 person, 33.33%
5. Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 1 person, 33.33%
6. Memory Loss: 1 person, 33.33%
7. Malignant Neoplasm Progression (cancer tumour came back): 1 person, 33.33%
8. Fever: 1 person, 33.33%
9. Drowsiness: 1 person, 33.33%
10. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 33.33%

---